Disetronic and TheraSense to Partner on FreeStyle Meter

Meter Measures BGs Using 0.3 Microliters of Blood

Dec 1, 2000

On September 18, the Disetronic Group announced it had reached an agreement with TheraSense of Alameda, California, to market and distribute the innovative FreeStyle blood glucose monitor.

Under the terms of the agreement, Disetronic will become the exclusive representative for marketing and distributing FreeStyle in Germany, Scandinavia, Holland, Austria and Switzerland. Disetronic will also market and distribute FreeStyle to its customers in the United States on a non-exclusive basis.

The FreeStyle enables people with diabetes to measure their blood glucose values using 0.3 microliters of blood. People with diabetes can obtain samples from the arm, which is less sensitive to pain than finger tips.

Disetronic plans to launch the FreeStyle in the European sales territory as soon as it receives market approval, probably early next year. In the United States, Disetronic plans to begin marketing the meter right away.

"This means Disetronic will be able to offer people with diabetes not only state-of-the-art pump technology, but also the latest method of measuring blood glucose values," says Thomas Meyer, CEO of the Disetronic Group. "We expect blood glucose monitoring and insulin delivery to become increasingly integrated in the future, resulting in further significant improvements in insulin therapy for millions of people with diabetes worldwide."

For more in-depth information on these two companies and this product, log onto www.diabetesinterview.com.

Click Here To View Or Post Comments

Categories: Blood Glucose, Diabetes, Diabetes, Insulin, Meters

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.